saffron
Saffron (Crocus Sativus) is a dietary supplement.
Crocus Sativus
Key facts
- Active ingredient
- Crocus Sativus
- Type
- Supplement
What is Saffron?
From the FDA label:A spice extract studied for mood and appetite support.
What the evidence says
Limited evidenceWhat Saffron is
Commonly used for
What the evidence shows
Typical dosage
Safety
Side effects
Interactions & cautions
This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Summarized from public health authorities; general reference, not medical advice. Talk to a licensed healthcare professional before starting any supplement.
Ways to save
Ask for the generic
Same active ingredient, far cheaper. Is there a generic? →
Request a 90-day supply
Bulk fills usually lower the per-dose price vs monthly refills.
Use copay cards
Manufacturer copay cards & patient-assistance programs — especially for brand drugs.
Compare alternatives
A same-class option may cost less. See alternatives →
Information is sourced from public FDA regulatory data. Provided for general reference only — not medical advice. Always consult a licensed professional and the current prescribing information.
What people report to the FDA about Crocus Sativus
The FDA Adverse Event Reporting System (FAERS) collects reports from patients and clinicians. It holds 2 reports naming Crocus Sativus — the active ingredient in Saffron, and the FDA flagged 100% of those reports as serious. The effects reported most often — leaving out reports about overdose, misuse or the condition being treated, which dominate the raw list for common medicines:
- abdominal discomfort1 reports
- abdominal pain upper1 reports
- ageusia1 reports
- anaemia1 reports
- asthenia1 reports
- blood creatinine increased1 reports
- carcinoembryonic antigen increased1 reports
- cardiac failure1 reports
Read these as a signal, not a rate. A report does not mean Crocus Sativus caused the effect — anyone can file one, and many describe people taking several medicines for several conditions. Crucially there is no denominator: FAERS does not record how many people took the drug, so these counts cannot be turned into “X% of patients” — a bigger number often just means a more widely used or more talked-about drug. Duplicates exist, and publicity drives reporting. For what is actually established, read the FDA label.
Source: openFDA drug/event (FAERS), retrieved September 25, 2026.
Reviews
No reviews yet. Be the first to write one.
People also viewed
Compare Saffron head-to-head
Browse medications A–Z
Research products from A to Z, compare independent ratings, and find alternatives.
saffron
New